VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 139 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $423,000 | -27.2% | 32,202 | -46.4% | 0.10% | -15.6% |
| Q3 2020 | $581,000 | +60.1% | 60,134 | +89.4% | 0.12% | +69.4% |
| Q2 2020 | $363,000 | -99.9% | 31,748 | -16.6% | 0.07% | +24.1% |
| Q3 2017 | $681,543,000 | +9.8% | 38,075 | 0.0% | 0.06% | +1.8% |
| Q2 2017 | $620,623,000 | -29.7% | 38,075 | -39.6% | 0.06% | -34.5% |
| Q1 2017 | $883,078,000 | – | 63,077 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |